These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19544224)

  • 1. Entecavir to treat severe acute hepatitis B.
    De Socio GV; Mercuri A; Di Candilo F; Baldelli F
    Scand J Infect Dis; 2009; 41(9):703-4. PubMed ID: 19544224
    [No Abstract]   [Full Text] [Related]  

  • 2. [New advances in the treatment of chronic hepatitis B: position of entecavir].
    Olaso V
    Rev Esp Quimioter; 2007 Sep; 20(3):259-60. PubMed ID: 18080023
    [No Abstract]   [Full Text] [Related]  

  • 3. Early hepatitis B virological rebound on entecavir through selection of lamivudine-associated mutations.
    Tong CY; Mullen JE; Wong T
    J Antimicrob Chemother; 2009 Oct; 64(4):875-7. PubMed ID: 19671587
    [No Abstract]   [Full Text] [Related]  

  • 4. Entecavir in HIV/HBV coinfection: possible HIV activity and resistance risk.
    AIDS Clin Care; 2007 Apr; 19(4):32. PubMed ID: 17695090
    [No Abstract]   [Full Text] [Related]  

  • 5. Entecavir.
    Opio CK; Lee WM; Kirkpatrick P
    Nat Rev Drug Discov; 2005 Jul; 4(7):535-6. PubMed ID: 16075486
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae.
    Jochum C; Gieseler RK; Gawlista I; Fiedler A; Manka P; Saner FH; Roggendorf M; Gerken G; Canbay A
    Digestion; 2009; 80(4):235-40. PubMed ID: 19828954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses.
    Soriano V; Sheldon J; García-Gasco P; Vispo E
    AIDS; 2007 Oct; 21(16):2253-4. PubMed ID: 18090058
    [No Abstract]   [Full Text] [Related]  

  • 8. [Entecavir - options and obstacles of an effective treatment for chronic hepatitis B].
    Cornberg M; Manns MP
    Dtsch Med Wochenschr; 2010 Jan; 135(1-2):32-7. PubMed ID: 20024882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in the treatment of acute hepatitis B].
    Mochida S; Fujiwara K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():248-52. PubMed ID: 15453324
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response.
    Baldick CJ; Eggers BJ; Fang J; Levine SM; Pokornowski KA; Rose RE; Yu CF; Tenney DJ; Colonno RJ
    J Hepatol; 2008 Jun; 48(6):895-902. PubMed ID: 18362040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preventive effect of entecavir on hepatitis B flare up in HBsAg(+) breast cancer patients receiving chemotherapy].
    Ding PP; He G
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):472-3. PubMed ID: 20587323
    [No Abstract]   [Full Text] [Related]  

  • 12. Common hepatitis B drug linked to HIV antiviral resistance.
    Future Microbiol; 2007 Apr; 2(2):104. PubMed ID: 17687802
    [No Abstract]   [Full Text] [Related]  

  • 13. Simultaneous acute myeloid leukaemia and de novo acute hepatitis B: a novel management strategy.
    Parrish C; Moreton P; Ashcroft J
    Leuk Res; 2011 Jun; 35(6):e67-8. PubMed ID: 21168208
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful Treatment of Hepatitis B Virus-associated Membranous Nephropathy with Entecavir and Immunosuppressive Agents.
    Ochi A; Ishimura E; Ichii M; Ohno Y; Nakatani S; Kobayashi I; Shima H; Tsuda A; Shidara K; Mori K; Tamori A; Inaba M
    Nephrology (Carlton); 2014 Sep; 19(9):595-6. PubMed ID: 25156438
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical characterization of peripheral neuropathy associated with entecavir in patients with HBV-induced cirrhosis].
    Zhang XH; Wu YK; Cao H; Wu ZB; Ke WM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):707-8. PubMed ID: 23320271
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA, Bristol-Myers Squibb issue warning on hepatitis B drug.
    AIDS Read; 2007 Oct; 17(10):478-510. PubMed ID: 17987701
    [No Abstract]   [Full Text] [Related]  

  • 17. [Entecavir. Treatment of chronic hepatitis b virus infections].
    Musch A
    Med Monatsschr Pharm; 2006 Nov; 29(11):392-6. PubMed ID: 17131685
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA notifications. Entecavir is approved for chronic hepatitis B infection in adults.
    AIDS Alert; 2005 Jul; 20(7):83-4. PubMed ID: 16114113
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy with entecavir in chronic hepatitis B. BEHoLD-Study (Benefits of Entecavir for Hepatitis B Liver Disease)].
    Nitschman S; Erhardt A; Häussinger A
    Internist (Berl); 2007 Feb; 48(2):208-10. PubMed ID: 17226008
    [No Abstract]   [Full Text] [Related]  

  • 20. Very few hepatitis trials recruiting.
    AIDS Patient Care STDS; 1998 Apr; 12(4):319-20. PubMed ID: 11361965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.